SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivimed Labs informs about press release

21 Sep 2015 Evaluate

Vivimed Labs has informed about a press release dated September 21, 2015, titled ‘Vivimed announces satisfactory Outcome of USFDA inspection’.

The above information is a part of company’s filings submitted to BSE.

Vivimed Labs Share Price

5.11 -0.05 (-0.97%)
24-Jul-2026 11:42 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1942.75
Dr. Reddys Labs. 1149.55
Cipla 1422.60
Lupin 2362.35
Zydus Lifesciences 1109.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: